How many employees does Vericel Corporation have?

Vericel Corporation reported 398 employees for the fiscal year ending Dec 2025, in the annual report it filed on February 26, 2026. That is up 11.5% from a year earlier.

What is Vericel Corporation's revenue per employee?

Vericel Corporation brought in $276M of revenue in fiscal Dec 2025, which is $694K per employee. That ranks 42 of 108 companies we track in Biotechnology, where the median is $459K.

Where do these numbers come from?

Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.

Company data

Vericel Corporation employees and revenue per employee

VCEL · Biotechnology · $2.05B market cap

Vericel Corporation had 398 employees at the end of fiscal Dec 2025, up 11.5% from a year earlier. Revenue for the year was $276M, up 16.5% from a year earlier, or $694K per employee. Revenue and headcount both grew, and revenue grew faster.

Employees

398

+11.5% YoY

Revenue

$276M

+16.5% YoY

Revenue / employee

$694K

Peer median $459K

Rank in industry

42 of 108

Biotechnology

Headcount against revenue

Both lines start at 100 in the first year we hold, so you can see which one grew faster.

EmployeesRevenueIndexed to 100 in Dec 2016

Hover a year for the numbers.

VCEL employees and revenue by fiscal year
Year ending	Employees	Revenue	Per employee	Staff YoY	Revenue YoY
Dec 2025	398	$276M	$694K	+11.5%	+16.5%
Dec 2024	357	$237M	$664K	+13.7%	+20.1%
Dec 2023	314	$198M	$629K	+3.0%	+20.2%
Dec 2022	305	$164M	$539K	+8.5%	+5.2%
Dec 2021	281	$156M	$556K	+2.9%	+25.8%
Dec 2020	273	$124M	$455K	+13.3%	+5.4%
Dec 2019	241	$118M	$489K	+11.6%	+29.7%
Dec 2018	216	$90.9M	$421K	+5.4%	+42.1%
Dec 2017	205	$63.9M	$312K	+1.5%	+17.5%
Dec 2016	202	$54.4M	$269K	—	—

Open roles: we have not matched a verified job board for this company yet.

Employees, last six fiscal years

Revenue per employee, last six fiscal years

Vericel Corporation against similar companies

The closest industry peers by revenue, from Biotechnology.

Company	Employees	Revenue	Revenue / employee	Shape
LGND Ligand Pharmaceuticals Incorporated	47	$268M	$5.70M	Leaner
RIGL Rigel Pharmaceuticals, Inc.	172	$294M	$1.71M	Efficient growth
CRMD CorMedix Inc.	191	$312M	$1.63M	Efficient growth
ARVN Arvinas, Inc.	246	$263M	$1.07M	Contracting
VCEL Vericel Corporation	398	$276M	$694K	Efficient growth
XERS Xeris Biopharma Holdings, Inc.	435	$292M	$671K	Efficient growth
ADPT Adaptive Biotechnologies Corporation	624	$277M	$444K	Efficient growth
RCUS Arcus Biosciences, Inc.	601	$247M	$411K	Contracting
IOVA Iovance Biotherapeutics, Inc.	975	$264M	$270K	Efficient growth

Every Healthcare company

Questions about Vericel Corporation

How many employees does Vericel Corporation have?: Vericel Corporation reported 398 employees for the fiscal year ending Dec 2025, in the annual report it filed on February 26, 2026. That is up 11.5% from a year earlier.
What is Vericel Corporation's revenue per employee?: Vericel Corporation brought in $276M of revenue in fiscal Dec 2025, which is $694K per employee. That ranks 42 of 108 companies we track in Biotechnology, where the median is $459K.
Where do these numbers come from?: Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.

Free game

Think you can pick better than the S&P 500?

Pick 15 stocks, lock them in, and we score them against the index every trading day for ten years. Free, with a public leaderboard.

Enter the challenge

More data

Compare VCEL with the rest of the market

See who earns the most per employee, who is hiring, and who is cutting, across every company we track.

Leaderboard Healthcare

Source: employee counts and revenue as stated in Vericel Corporation's annual reports (Form 10-K), latest filed February 26, 2026. This is data, not a recommendation to buy or sell VCEL.